MENU
PASG
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Passage Bio (PASG) Earnings Date & Reports

Passage Bio Inc is a genetic medicines company... Show more

A.I. Advisor
published Earnings

PASG is expected to report earnings to rise 25.00% to -25 cents per share on May 19

Passage Bio PASG Stock Earnings Reports
Q1'25
Est.
$-0.25
Q4'24
Beat
by $0.03
Q3'24
Missed
by $0.08
Q2'24
Beat
by $0.05
Q1'24
Beat
by $0.05
The last earnings report on March 04 showed earnings per share of -20 cents, beating the estimate of -22 cents. With 44.55K shares outstanding, the current market capitalization sits at 24.30M.
View a ticker or compare two or three
PASG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a genetic medicines company, which focuses on developing transformative therapies for rare, monogenic central nervous system disorders with limited or no approved treatment options

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
2005 Market Street
Phone
+1 267 866-0311
Employees
58
Web
https://www.passagebio.com